The Role of Cyclooxygenase‐2 in the Development of Steatohepatitis

Guiying Li,Chang Han,Lihong Xu,Tong Wu
DOI: https://doi.org/10.1096/fasebj.23.1_supplement.117.2
2009-01-01
Abstract:This study was designed to investigate the role of cyclooxygenase‐2 (COX‐2) in the pathogenesis of steatohepatitis by using COX‐2 transgenic and knockout mice fed methionine‐and choline‐deficient (MCD) diet. We generated transgenic (Tg) mice with targeted expression of COX‐2 in the liver by using the albumin promoter‐enhancer driven vector. The COX‐2 transgenic (Tg), COX‐2 knockout (KO) and wild type mice were fed with MCD diet or normal diet for 3 weeks. Liver injury was assessed by histopathological examination and measurement of serum ALT and AST levels. Liver tissues were obtained for Western blot analysis. Hepatic triglycerides and lipid peroxide levels were determined. Our data showed that with the MCD diet, the COX‐2 Tg mice exhibited significantly elevated serum ALT and AST, higher levels of hepatic triglycerides and lipid peroxide, and more prominent hepatic steatosis and inflammation when compared to wild type mice (p<0.01). The COX‐2 KO mice showed significantly less liver injury than the COX‐2 Tg or wild type mice when these animals were placed on MCD diet. Western blot analysis revealed that transgenic expression of COX‐2 increases the accumulation of PPAR (peroxisome proliferator‐activated receptor)‐γ and cannabinoid CB1 receptor in the liver tissue. These findings suggest that hepatocyte COX‐2 facilitates the development of steatohepatitis and this effect may involve PPARγ and CB1.
What problem does this paper attempt to address?